Frederick R Ahmann

  • 4458 Citations
  • 30 h-Index
1979 …2017
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Frederick R Ahmann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Prostate-Specific Antigen Medicine & Life Sciences
Prostate Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Digital Rectal Examination Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Fluorouracil Medicine & Life Sciences
Selenium Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1998 2011

Selenium
Prostatic Neoplasms
Prostate
Biopsy
Incidence

PHASE II CHEMOPREVENTION TRIAL OF SE AND PROSTATE CANCER

Ahmann, F. R., Marshall, J. & Clark, L.

National Institutes of Health

9/30/988/31/09

Project: Research project

Chemoprevention
Selenium
Prostatic Neoplasms
Watchful Waiting
Disease Progression

Research Output 1979 2017

  • 4458 Citations
  • 30 h-Index
  • 83 Article
  • 4 Chapter
16 Citations (Scopus)

Comparison of Digital Rectal Examination and Serum Prostate Specific Antigen in the Early Detection of Prostate Cancer: Results of a Multicenter Clinical Trial of 6,630 Men

Catalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, ML. A., Scardino, P. T., Flanigan, R. C., DeKernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., Waters, W. B., MacFarlane, M. T. & Southwick, P. C., Feb 1 2017, In : Journal of Urology. 197, 2, p. S200-S207

Research output: Contribution to journalArticle

Digital Rectal Examination
Prostate-Specific Antigen
Early Detection of Cancer
Multicenter Studies
Prostatic Neoplasms
53 Citations (Scopus)

Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer

Algotar, A. M., Stratton, M. S., Ahmann, F. R., Ranger-Moore, J., Nagle, R. B., Thompson, P. A., Slate, E., Hsu, C-H., Dalkin, B. L., Sindhwani, P., Holmes, M. A., Tuckey, J. A., Graham, D. L., Parnes, H. L., Clark, L. C. & Stratton, S. P., Feb 15 2013, In : Prostate. 73, 3, p. 328-335 8 p.

Research output: Contribution to journalArticle

Phase III Clinical Trials
Selenium
Prostatic Neoplasms
Prostate-Specific Antigen
Placebos
91 Citations (Scopus)

A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer

Tolcher, A. W., Quinn, D. I., Ferrari, A., Ahmann, F. R., Giaccone, G., Drake, T., Keating, A. & De Bono, J. S., Apr 2012, In : Annals of Oncology. 23, 4, p. 968-973 6 p.

Research output: Contribution to journalArticle

Castration
Prostatic Neoplasms
docetaxel
Prostate-Specific Antigen
Disease-Free Survival
1 Citation (Scopus)

Differences in characteristics of men with localised prostate cancer who demonstrate low, intermediate or high prostate-specific antigen velocity

Algotar, A. M., Thompson, P. A., Ranger-Moore, J., Stratton, M. S., Hsu, C-H., Ahmann, F. R., Nagle, R. B. & Stratton, S. P., Apr 2012, In : Internal Medicine Journal. 42, 4, p. 374-380 7 p.

Research output: Contribution to journalArticle

Prostate-Specific Antigen
Prostatic Neoplasms
Aspirin
Smoking
Odds Ratio
82 Citations (Scopus)
Prostatectomy
Polyphenols
Tea
Prostatic Neoplasms
Placebos